The intramammary efficacy of first generation cephalosporins against Staphylococcus aureus mastitis in mice

Veterinary Microbiology

Volumn 160, Issue 1-2, 2012, Pages 141-150

  Demon, Dieter ^a   Ludwig, Carolin ^b   Breyne, Koen ^a   Guédé, David ^c   Dörner, Julia Charlotte ^b   Froyman, Robrecht ^b   Meyer, Evelyne ^a  

^a GHENT UNIVERSITY   (Belgium)

^b BAYER AG   (Germany)

^c ClinBAY sprl ^*  (Belgium)

Author keywords

Antimicrobials; Mammary gland; Mastitis; Mouse model; S. aureus

Indexed keywords

CEFALEXIN; CEFALONIUM; CEFAPIRIN; CEFAZOLIN; CEPHALOSPORIN DERIVATIVE; MIGLYOL; MINERAL OIL; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DOSE RESPONSE; DRUG DOSE TITRATION; DRUG EFFICACY; IN VITRO STUDY; IN VIVO STUDY; LOW DRUG DOSE; MASTITIS; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ANIMALS; ANTI-INFECTIVE AGENTS; CATTLE; CEPHALOSPORINS; DISEASE MODELS, ANIMAL; FEMALE; LACTATION; MASTITIS, BOVINE; MICE; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

BOS; BOVINAE; MUS; STAPHYLOCOCCUS AUREUS;

EID: 84866983949     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2012.05.017     Document Type: Article

References (38)

1. Anderson J.C., Craven N. Assessment in the mouse of cefoperazone as a treatment for mastitis. Vet. Rec. 1984, 114:607-612.
2. Apparao M.D., Ruegg P.L., Lago A., Godden S., Bey R., Leslie K. Relationship between in vitro susceptibility test results and treatment outcomes for gram-positive mastitis pathogens following treatment with cephapirin sodium. J. Dairy Sci. 2009, 92:2589-2597.
3. Barkema H.W., Schukken Y.H., Zadoks R.N. Invited review: the role of cow, pathogen, and treatment regimen in the therapeutic success of bovine Staphylococcus aureus mastitis. J. Dairy Sci. 2006, 89:1877-1895.
4. BCFI Gecommentarieerd Geneesmiddelenrepertorium voor Diergeneeskundig Gebruik 2011, Belgisch Centrum voor Farmacotherapeutische Informatie, vzw, Brussels, Belgium.
5. Bradley A.J., Breen J.E., Payne B., Williams P., Green M.J. The use of a cephalonium containing dry cow therapy and an internal teat sealant, both alone and in combination. J. Dairy Sci. 2010, 93:1566-1577.
6. Brix A.C. Untersuchung zu minimalen Hemmkonzentrationen von antimikrobiellen Wirkstoffen gegenüber bovinen Mastitiserregern 2007, Tierärztliche Hochschule Hannover, Hannover.
7. Brouillette E., Grondin G., Lefebvre C., Talbot B.G., Malouin F. Mouse mastitis model of infection for antimicrobial compound efficacy studies against intracellular and extracellular forms of Staphylococcus aureus. Vet. Microbiol. 2004, 101:253-262.
8. Brouillette E., Malouin F. The pathogenesis and control of Staphylococcus aureus-induced mastitis: study models in the mouse. Microbes Infect./Institut Pasteur 2005, 7:560-568.
9. CLSI Performance standards for antimicobial disk and dilution susceptibility tests for bacteria isolated from animals 2008, Clinical and Laboratory Standards Institute. third ed.
10. Erskine R.J., Walker R.D., Bolin C.A., Bartlett P.C., White D.G. Trends in antibacterial susceptibility of mastitis pathogens during a seven-year period. J. Dairy Sci. 2002, 85:1111-1118.
11. EUCAST Data from the European Committee on Antimicrobial Susceptibility Testing (EUCAST) MIC distribution website 2011, (last accessed 13-03-2012). http://www.eucast.org/.
12. Gehring R., Smith G.W. An overview of factors affecting the disposition of intramammary preparations used to treat bovine mastitis. J. Vet. Pharmacol. Ther. 2006, 29:237-241.
13. Groothuis D.G., Frik J.F. Comparison of the sensitivity patterns of Staphylococci isolated from bovine udders in 1974 and 1980. Tijdschr. Diergeneeskd. 1982, 107:883-888.
14. Gruet P., Maincent P., Berthelot X., Kaltsatos V. Bovine mastitis and intramammary drug delivery: review and perspectives. Adv. Drug Deliv. Rev. 2001, 50:245-259.
15. Gudding R., McDonald J.S., Cheville N.F. Pathogenesis of Staphylococcus aureus mastitis: bacteriologic, histologic, and ultrastructural pathologic findings. Am. J. Vet. Res. 1984, 45:2525-2531.
16. Guerin-Faublee V., Carret G., Houffschmitt P. In vitro activity of 10 antimicrobial agents against bacteria isolated from cows with clinical mastitis. Vet. Rec. 2003, 152:466-471.
17. Kaspar H. Results of the antimicrobial agent susceptibility study raised in a representative, cross-sectional monitoring study on a national basis. Int. J. Med. Microbiol. 2006, 296(Suppl. 41):69-79.
18. Maneke E., Pridmore A., Goby L., Lang I. Kill rate of mastitis pathogens by a combination of cefalexin and kanamycin. J. Appl. Microbiol. 2011, 110:184-190.
19. Maran Monitoring of Antimicrobial Resistance and Antibiotic Usage in Animals in the Netherlands in 2008 2010, http://www.cvi.wur.nl/NR/rdonlyres/A906A4C0-A458-423E-B932-28F222385988/110563/MARAN_2008_definitief_corrected.pdf.
20. Moroni P., Pisoni G., Antonini M., Villa R., Boettcher P., Carli S. Short communication: antimicrobial drug susceptibility of Staphylococcus aureus from subclinical bovine mastitis in Italy. J. Dairy Sci. 2006, 89:2973-2976.
21. N.M.C. A global organisation for mastitis control and milk quality. Recommended Mastitis Control Program 2006, National Mastitis Council Inc., Madison, WI. http://www.nmconline.org/docs/NMCchecklistInt.pdf.
22. Nunes S.F., Bexiga R., Cavaco L.M., Vilela C.L. Technical note: antimicrobial susceptibility of Portuguese isolates of Staphylococcus aureus and Staphylococcus epidermidis in subclinical bovine mastitis. J. Dairy Sci. 2007, 90:3242-3246.
23. Owens W.E., Ray C.H., Watts J.L., Yancey R.J. Comparison of success of antibiotic therapy during lactation and results of antimicrobial susceptibility tests for bovine mastitis. J. Dairy Sci. 1997, 80:313-317.
24. Piepers S., De Meulemeester L., de Kruif A., Opsomer G., Barkema H.W., De Vliegher S. Prevalence and distribution of mastitis pathogens in subclinically infected dairy cows in Flanders, Belgium. J. Dairy Res. 2007, 74:478-483.
25. Prasad L.B., Newbould F.H. Inoculation of the bovine teat duct with Staphylococcus aureus: the relationship of teat duct length, milk yield and milking rate to development of intramammary infection. Can. Vet. J. 1968, 9:107-115.
26. Roy J.P., DesCoteaux L., DuTremblay D., Beaudry F., Elsener J. Efficacy of a 5-day extended therapy program during lactation with cephapirin sodium in dairy cows chronically infected with Staphylococcus aureus. Can. Vet. J. 2009, 50:1257-1262.
27. Salmon S.A., Watts J.L., Aarestrup F.M., Pankey J.W., Yancey R.J. Minimum inhibitory concentrations for selected antimicrobial agents against organisms isolated from the mammary glands of dairy heifers in New Zealand and Denmark. J. Dairy Sci. 1998, 81:570-578.
28. Sasol, 2004. Sasol Germany GmbH; http://abstracts.aapspharmaceutica.com/expoaaps07/Data/EC/Event/Exhibitors/263/cb63fb76-28f4-4948-a6d0-ae249dae9c30.pdf.
29. Sato K., Bennedsgaard T.W., Bartlett P.C., Erskine R.J., Kaneene J.B. Comparison of antimicrobial susceptibility of Staphylococcus aureus isolated from bulk tank milk in organic and conventional dairy herds in the midwestern United States and Denmark. J. Food Prot. 2004, 67:1104-1110.
30. Schukken Y.H., Leslie K.E., Barnum D.A., Mallard B.A., Lumsden J.H., Dick P.C., Vessie G.H., Kehrli M.E. Experimental Staphylococcus aureus intramammary challenge in late lactation dairy cows: quarter and cow effects determining the probability of infection. J. Dairy Sci. 1999, 82:2393-2401.
31. Stanish W.M., Taylor N. Estimation of the intraclass correlation coefficient for the analysis of covariance model. The American Statistician (American Statistical Association) 1983, 37:221-224.
32. Tenhagen B.A., Hansen I., Reinecke A., Heuwieser W. Prevalence of pathogens in milk samples of dairy cows with clinical mastitis and in heifers at first parturition. J. Dairy Res. 2009, 76:179-187.
33. Van Bambeke F., Barcia-Macay M., Lemaire S., Tulkens P.M. Cellular pharmacodynamics and pharmacokinetics of antibiotics: current views and perspectives. Curr. Opin. Drug Discov. Devel. 2006, 9:218-230.
34. Watts J.L., Salmon S.A., Yancey R.J., Nickerson S.C., Weaver L.J., Holmberg C., Pankey J.W., Fox L.K. Antimicrobial susceptibility of microorganisms isolated from the mammary glands of dairy heifers. J. Dairy Sci. 1995, 78:1637-1648.
35. Yancey R.J., Kinney M.L., Roberts B.J., Goodenough K.R., Hamel J.C., Ford C.W. Ceftiofur sodium, a broad-spectrum cephalosporin: evaluation in vitro and in vivo in mice. Am. J. Vet. Res. 1987, 48:1050-1053.
36. Yoshimura H., Ishimaru M., Kojima A. Minimum inhibitory concentrations of 20 antimicrobial agents against Staphylococcus aureus isolated from bovine intramammary infections in Japan. J. Vet. Med. B: Infect. Dis. Vet. Public Health 2002, 49:457-460.
37. Zadoks R., Fitzpatrick J. Changing trends in mastitis. Ir. Vet. J. 2009, 62(Suppl. 4):S59-S70.
38. Zadoks R.N., Middleton J.R., McDougall S., Katholm J., Schukken Y.H. Molecular epidemiology of mastitis pathogens of dairy cattle and comparative relevance to humans. J. Mammary Gland Biol. Neoplasia 2011, 16:357-372.